Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
12/19/14 Cubist (CBST) Zerbaxa for Urinary Tract and Reproductive Tract Infections (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
12/19/14 AstraZeneca (AZN) Lynparza for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
12/19/14 Roche (ROG:VX) Gantenerumab for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only
12/18/14 Roche (ROG:VX) Kadcyla for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
12/18/14 Pfizer (PFE) Lyrica CR for Postherpetic Neuralgia (PHN) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
12/22/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
12/22/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 12/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
12/23/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 12/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement